From: Efficacy of tailored second-line therapy of Helicobacter pylori eradication in patients with clarithromycin-based treatment failure: a multicenter prospective study
Eradication rate
ALEB therapy subgroup (n = 51)
Combined AFEB therapy subgroup (n = 131)
LBQT group (n = 182)
ITT analysis
44/51 (86.3%)
119/131 (90.8%)
118/182 (64.8%)
PP analysis
44/50 (88.0%)
119/129 (92.2%)
118/174 (67.8%)